Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 29, 2025 16:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options

CARGO Therapeutics to Discontinue FIRCE-1 Phase 2 Study of Firi-cel; Advances Remaining Programs While Evaluating Strategic Options
January 27, 2025 08:05 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma Announces Appointment of Dr. Luke Walker as Chief Medical Officer

SEATTLE, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today...
January 14, 2025 07:00 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma Announces Oversubscribed $100 Million Series C Financing to Advance In Vivo CAR T Pipeline through Key Oncology Clinical Milestones

Series C financing co-led by Double Point Ventures and DCVC Bio Proceeds to support the clinical development of VivoVec™ derived in vivo CAR T cells SEATTLE, Jan. 14, 2025 (GLOBE NEWSWIRE) --...
January 06, 2025 16:30 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

SEATTLE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo cell therapies that aim to realize the full reach and promise of CAR T cells, today...
December 17, 2024 08:00 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

CARGO Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference
November 26, 2024 09:05 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma to Present at the 7th Annual Evercore ISI HealthCONx Conference

SEATTLE, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf cell therapies that aim to realize the full reach and promise of...
November 21, 2024 08:05 ET | Source: Umoja Biopharma, Inc.

Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors

SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf therapies that aim to realize the full reach and promise of CAR...
November 12, 2024 16:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

CARGO Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
November 05, 2024 16:05 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics to Participate in Upcoming Investor Conferences

CARGO Therapeutics to Participate in Upcoming Investor Conferences
November 05, 2024 09:23 ET | Source: Cargo Therapeutics, Inc.

CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma Activity

CARGO Therapeutics Announces ASH 2024 Abstract on CRG-023, a Tri-specific CAR T, Highlighting Innovative Construct Design and Durable Anti-B-Cell Lymphoma

Next Page keyboard_arrow_right